Status: Recruiting
Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus
The objective of this study is to investigate the efficacy of implementing the AI-SaMD(VUNO Med®-Fundus AI™) alongside routine clinical practice for the detection of diabetic retinopathy.
Participants needed: 340
Trial details
Age: 19+Biological sex: AllType: InterventionalSponsor: VUNO Inc.Updated: Apr 13, 2026Locations: 1
Eligibility criteria
Adults aged 19 years or older. [+2]
A prior diagnosis of diabetic retinopathy at the time of screening. [+4]